Browse by Phase
Phase 2 Clinical Trials
Phase 2 trials study whether a drug works in people with a specific disease or condition. These studies enroll 100–300 participants and also continue to evaluate safety.
Total Trials
1,071
Recruiting Now
1,071
Top Conditions in Phase 2
NCT04195633 Phase 2
Recruiting
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiat...
Condition
Acute Leukemia
Enrollment
60 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT03736863 Phase 2
Recruiting
A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treat...
Condition
Esophageal Cancer
Enrollment
147 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT06901687 Phase 2
Recruiting
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Mult...
Condition
Multiple Sclerosis
Enrollment
170 pts
Location
United States
Sponsor
NYU Langone Health
NCT06249321 Phase 2
Recruiting
mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic...
Condition
Pancreatic Cancer
Enrollment
30 pts
Location
China
Sponsor
Fudan University
NCT07438106 Phase 2
Recruiting
A Phase III Study of HRS-4642 Combined With AG (Nab-paclitaxel and Gemcitabine) ...
Condition
Locally Advanced Pancreatic Cancer With KRAS G12D Mutation
Enrollment
30 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT06558604 Phase 2
Recruiting
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantl...
Condition
Lymphoma, Mantle-Cell
Enrollment
100 pts
Location
Belgium, France
Sponsor
The Lymphoma Academic Research
NCT06291064 Phase 2
Recruiting
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Condition
Triple Negative Breast Cancer
Enrollment
85 pts
Location
Nigeria
Sponsor
University of Chicago
NCT04965064 Phase 2
Recruiting
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic B...
Condition
Breast Cancer
Enrollment
22 pts
Location
United States
Sponsor
University of Rochester
NCT03740204 Phase 2
Recruiting
The Role of Estrogen in the Neurobiology of Eating Disorders
Condition
Eating Disorders
Enrollment
120 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT05414032 Phase 2
Recruiting
Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV...
Condition
Locoregionally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC)
Enrollment
102 pts
Location
Canada
Sponsor
University Health Network, Tor
NCT06474598 Phase 2
Recruiting
An Adaptive Design Study of MTX228
Condition
Type 1 Diabetes Mellitus
Enrollment
24 pts
Location
Canada
Sponsor
University of Alberta
NCT04857164 Phase 2
Recruiting
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for ...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
150 pts
Location
China
Sponsor
Yuankai Shi
NCT06840834 Phase 2
Recruiting
Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patient...
Condition
Pleural Mesotheliomas
Enrollment
38 pts
Location
France
Sponsor
Intergroupe Francophone de Can
NCT06340711 Phase 2
Recruiting
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophago...
Condition
Esophageal Adenocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT06668571 Phase 2
Recruiting
Intravenous Ketamine for Treatment-Resistant Depression
Condition
Depressive Disorder, Treatment-Resistant
Enrollment
30 pts
Location
United States
Sponsor
Mayo Clinic
NCT07169344 Phase 2
Recruiting
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients...
Condition
Soft Tissue Sarcoma (Excluding GIST)
Enrollment
110 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT05281809 Phase 2
Recruiting
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma an...
Condition
B-Cell Lymphoma
Enrollment
30 pts
Location
United States
Sponsor
John Lister
NCT06406634 Phase 2
Recruiting
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemoth...
Condition
Hepatocellular Carcinoma
Enrollment
30 pts
Location
China
Sponsor
Hunan Cancer Hospital
NCT07132021 Phase 2
Recruiting
Efficacy of Trans-auricular Vagus Nerve Stimulation on Upper Extremity Motor Rec...
Condition
Stroke
Enrollment
30 pts
Location
Brazil
Sponsor
Universidade Federal de Pernam
NCT06991114 Phase 2
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Ther...
Condition
Refractory Rheumatoid Arthritis (RA)
Enrollment
90 pts
Location
United States, Bulgaria, France
Sponsor
Artiva Biotherapeutics, Inc.
NCT06658834 Phase 2
Recruiting
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult...
Condition
Primary Immune Thrombocytopenia
Enrollment
129 pts
Location
China
Sponsor
Institute of Hematology & Bloo
NCT05406999 Phase 2
Recruiting
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostat...
Condition
Neoadjuvant Therapy
Enrollment
900 pts
Location
China
Sponsor
The Affiliated Nanjing Drum To
NCT04481932 Phase 2
Recruiting
Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive...
Condition
HER2-positive Breast Cancer
Enrollment
104 pts
Location
China
Sponsor
Peking University
NCT06488898 Phase 2
Recruiting
Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical ...
Condition
Aortic Aneurysm, Abdominal
Enrollment
8 pts
Location
Spain
Sponsor
Instituto de Investigación Hos
NCT05636787 Phase 2
Recruiting
Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi®...
Condition
Multiple Myeloma
Enrollment
120 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho
Page 1 of 43 — 1,071 trials total